Rilpivirine

Details

Files

Generic Name:

Rilpivirine

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

July 15, 2011

Brand Name:

Edurant

Project Line:

Reimbursement Review

Project Number:

SR0243-000

Call for patient/clinician input closed:

August 22, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV (treatment - naive adult)

Recommendation Type:

List

Final Recommendation:

February 15, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 29, 2011